LUMICKS

LUMICKS is a life science tools company focused on developing cutting-edge technology to empower researchers with tools that unlock the measurement of forces and interactions in biology. Their primary focus is on providing innovative instruments for dynamic single-molecule (DSM) analysis and cell-binding avidity (CA) analysis. By applying and measuring forces around biological interactions, LUMICKS enables the detailed real-time analysis of underlying biological mechanisms at both the molecular and cellular level. This approach allows researchers to directly link structural and 'omics analysis to functional outcomes, accelerating research and drug development in various fields, such as neurodegeneration, oncology, and rare genetic diseases.

LUMICKS differentiates itself with a deep biophysics expertise, utilizing Nobel-prize-winning technologies like optical tweezers and STED super-resolution. Their product portfolio includes the C-Trap® Optical Tweezers, the m-Trap® Optical Tweezers, and the z-Movi® Cell Avidity Analyzer. In addition to their instruments, LUMICKS offers a range of reagents, kits, and services to support researchers in their dynamic single-molecule experiments. Their goal is to advance science and improve human health through their innovative technologies.

LUMICKS offers a flexible work environment, as described by employees in their testimonials. They emphasize the company's flat structure that allows employees to think creatively and be their own person at work. The international team and friendly, approachable, and helpful colleagues also contribute to a positive and flexible work experience. However, specific details about remote work options or flexible hours are not provided.

LUMICKS is a life science tools company focused on advancing science and improving human health by providing tools that unlock the measurement of forces and interactions in biology. They aim to empower researchers with unparalleled insight into the fundamental cause of disease and the potential for drug optimization by developing cutting-edge technologies in dynamic single-molecule (DSM) analysis and cell-binding avidity (CA) analysis. Their goal is to bridge the gap between structural and ‘omics analysis to functional outcomes, ultimately accelerating research, drug development, bioprocessing, bioproduction quality control, and patient treatment.

LUMICKS promotes a culture of collaboration, innovation, and growth. They value open-mindedness, teamwork, and a willingness to embrace challenges. The company emphasizes ownership, encouraging employees to be creative and take initiative. With a diverse international team, employees are exposed to various perspectives and experiences, fostering a supportive and inclusive environment.

LUMICKS actively promotes a diverse, equitable, and inclusive workplace by prioritizing a culture of openness, respect, and collaboration. This is demonstrated through their diverse team with over 30 nationalities, initiatives to embrace challenges and maximize opportunities, and their commitment to a flat company structure which allows employees to be creative and express themselves.